SERPINH1 and breast carcinoma: Cervical cancer (Yamamoto et al., 2013), breast cancer (Lai et al., 2017; Zhu et al., 2015), glioblastoma (Zhao et al., 2014), and colorectal cancer (Mori et al., 2017) all have abnormal expression of SERPINH1.